Starling Oncology (STLNW) Capital Expenditures (QoQ) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Capital Expenditures (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.86% |
| Mar 31, 2026 | -1.70% |
| Dec 31, 2025 | 75.50% |
| Sep 30, 2025 | -50.00% |
| Jun 30, 2025 | 268.29% |
| Mar 31, 2025 | -81.31% |
| Dec 31, 2024 | 536.57% |
| Sep 30, 2024 | -122.02% |
| Jun 30, 2024 | 199.34% |
| Mar 31, 2024 | -29.15% |
| Dec 31, 2023 | -7.42% |
| Sep 30, 2023 | -0.75% |
| Jun 30, 2023 | -49.05% |
| Mar 31, 2023 | -7.82% |
| Dec 31, 2022 | 67.65% |
| Sep 30, 2022 | -11.33% |
| Jun 30, 2022 | 33.93% |
| Mar 31, 2022 | 15.04% |
| Dec 31, 2021 | -8.32% |
| Sep 30, 2021 | 133.42% |